- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01636258
FRESH Study (Fitness, Relaxation and Eating to Stay Healthy) (FRESH)
May 6, 2022 updated by: Linda Libertini, The Cleveland Clinic
Diet, Exercise, Cooking, and Stress Management for Patients With Prediabetes: A Pilot Randomized Controlled Study
To examine whether a lifestyle program results in weight loss and thereby delays or prevents progression of pre-diabetes to diabetes, we propose a pilot randomized controlled trial of 6 weeks duration with 30 participants held at Stephanie Tubbs Jones Health Center.
Participants are randomized to receive all of the following: nutrition education, exercise instruction, stress management instruction, and culinary education or follow usual care.
Outcomes include: blood sugars and cholesterol, weight, waist circumference, blood pressure, diet, physical activity, perceived stress, and class attendance.
Analysis is by Intention to treat analysis of variance.
Results will be used to help design larger randomized trial in the future.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Control group:
These participants will continue to receive their usual care from their primary medical care team.
Intervention group:
The participants will receive nutrition education, exercise instruction, stress management instruction,and culinary education
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
East Cleveland, Ohio, United States, 44112
- Stephanie Tubbs Jones Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Study participants must:
- Be capable of giving informed consent
- Understand and voluntarily sign the informed consent form.
- Be females at least 18 years of age and identify themselves as African-American
- Have prediabetes as defined by the American Diabetes Association: history of glycated hemoglobin (HgbA1c) 5.7-6.4 % or fasting blood glucose 100-125 mg/dL (5.6-6.9 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose 140-199 mg/dL (7.8-11.0 mmol/L) during an oral glucose tolerance test (as described by the World Health Organization using a glucose load of 75 g anhydrous glucose dissolved in water)
- Have a body mass index (BMI, defined as weight in kilograms divided by height in meters squared) greater than or equal to 25
Exclusion Criteria:
- Current or previous diagnosis of diabetes or a history of HgbA1c ≥ 6.5% or fasting blood glucose ≥ 126 mg/dL (7.0 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose ≥ 200 mg/dL (11.1 mmol/L) during an oral glucose tolerance test or a history of classic symptoms of hyperglycemia or hyperglycemic crisis and a random plasma glucose ≥ 200 mg/dL (11.1 mmol/L).
- Normal glycemia or a currently with a HgbA1c < 5.7% or fasting blood glucose < 100 mg/dL (7.0 mmol/L) (fasting defined as no caloric intake for at least 8 hours), or a 2-hour plasma glucose < 140 mg/dL (11.1 mmol/L) during an oral glucose tolerance test
- Current or past use of oral hypoglycemic agents (including, but not limited to, metformin, rosiglitazone, pioglitazone, glipizide, and glyburide) or insulin
- Male gender
- History of congestive heart failure
- History of renal failure, dialysis, or creatinine greater than 2 mg/dL
- History of liver failure or a liver dysfunction with a increase by a factor of 2 above the upper limit of normal in alanine aminotransferase or aspartate aminotransferase
- History of gastrointestinal disorder that would prevent adherence to the recommended diet (e.g. celiac disease, inflammatory bowel disease, history of bariatric surgery, history of intestinal surgery)
- Presence of active cancer
- History of coronary artery disease or cerebrovascular disease
- History of uncontrolled hypertension
- Participation in another lifestyle modification trial
- Pregnancy or lactating or planning to be pregnant
- Current alcoholism or abuse of recreational drugs
- Hospitalization for depression in past 12 months
- Travel plans that do not permit full participation or participant lives too far from Health Center to permit full participation
- History of bariatric surgery, small bowel resection, or extensive bowel resection
- Chronic treatment with systemic steroids
- Current diagnosis of schizophrenia, other psychotic disorders, or bipolar disorder
- Inability to walk two blocks
- Other medial, psychiatric, or behavioral limitations that in the judgment of the principal investigator may interfere with study participation or the ability to follow the intervention protocol
- Amputation of lower limb for nontraumatic causes
- Self report of HIV-positivity or active tuberculosis
- Documented history of pulmonary embolus in past six months
- Chronic obstructive pulmonary disease that would limit ability to follow the study protocol
- Self-reported chronic hepatitis B or C or cirrhosis; inflammatory bowel disease requiring treatment in past year; Cushing's syndrome; acromegaly (clinical diagnosis or self-report); any major organ transplant
- Unwilling or uninterested in participating in group lifestyle education sessions
- Current regular corticosteroid use
- Active polycystic ovarian syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Arm A: Control group
These participants will continue to receive their usual care from their primary medical care team.
|
|
|
Experimental: Arm B
Arm includes diet instruction, exercise, stress management, and culinary education
|
Every other week
Every other week
Every week
Every other week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of "FRESH" Program on Weight Loss
Time Frame: Baseline line and final followup visit (at 8-14 weeks)
|
Change in weight measured at baseline and followup (at 8-14 weeks).
|
Baseline line and final followup visit (at 8-14 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diet - Daily Calorie Intake
Time Frame: Baseline and final followup visit (at 8-14 weeks)
|
Change in daily caloric intake as measured by online 24-hour recall dietary program
|
Baseline and final followup visit (at 8-14 weeks)
|
|
Exercise
Time Frame: Baseline and final followup visits (at 8-14 weeks)
|
Change in 7-day average steps/day as measured by pedometer at baseline and followup (at 8-14 weeks).
|
Baseline and final followup visits (at 8-14 weeks)
|
|
Stress
Time Frame: baseline and followup visit (at 8-14 weeks)
|
Change of Psychosocial Stress (PSS-10) scores (total range 0-40) measured at baseline and followup (at 8-14 weeks).
Higher score reflects worse outcome.
|
baseline and followup visit (at 8-14 weeks)
|
|
Sleep
Time Frame: baseline and followup visit (at 8-14 weeks)
|
Change in self-reported average hours of sleep/night measured at baseline and followup (at 8-14 weeks).
|
baseline and followup visit (at 8-14 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Adam M Bernstein, M.D., The Cleveland Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2012
Primary Completion (Actual)
October 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
July 5, 2012
First Submitted That Met QC Criteria
July 5, 2012
First Posted (Estimate)
July 10, 2012
Study Record Updates
Last Update Posted (Actual)
May 10, 2022
Last Update Submitted That Met QC Criteria
May 6, 2022
Last Verified
May 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-340
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
Clinical Trials on Stress Management
-
Massachusetts General HospitalNational Center for Complementary and Integrative Health (NCCIH)CompletedStress, Psychological | Stress, PhysiologicalUnited States
-
Oslo University HospitalNorwegian Cancer SocietyActive, not recruitingCancer | Stress, PsychologicalNorway
-
Amit SoodCompleted
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosis 2United States
-
McGill UniversityCompletedStress | Well-being | Mindfulness | Adherence | Coping | Behaviour Change | Digital InterventionCanada
-
Massachusetts General HospitalThe Children's Tumor FoundationCompletedNeurofibromatosesUnited States
-
Massachusetts General HospitalRecruitingIBD (Inflammatory Bowel Disease)United States
-
University of Colorado, DenverCompleted
-
Monash UniversityCompleted
-
Erasmus Medical CenterIndigo Rijnmond, the Netherlands; Avant Sanare, The Netherlands; Erasmus University...UnknownSmoking | Smoking Cessation | Stress | Stress, Psychological | Health Behavior | Smoking, Tobacco | Smoking, CigaretteNetherlands